Patents by Inventor Matthew F. Mescher

Matthew F. Mescher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5045320
    Abstract: Immunization and/or therapeutic in vivo introduction of ligands bound alone or in combination with other molecules, arrayed on solid supports having greater then about 0.2.mu. diameter to elicit and augment in vivo T cell mediated responses are described.
    Type: Grant
    Filed: March 23, 1989
    Date of Patent: September 3, 1991
    Assignee: Medical Biology Institute
    Inventor: Matthew F. Mescher
  • Patent number: 4722842
    Abstract: A purified growth inhibitory factor comprising a lipid-like compound derived from or substantially similar to the factor present in lymphocyte or liver cell plasma membranes is capable of inhibiting cytolytic T-lymphocyte killing response and mitogen-induced B cell, T cell, or lymphoid tumor cell proliferation.
    Type: Grant
    Filed: October 11, 1985
    Date of Patent: February 2, 1988
    Assignee: President and Fellows of Harvard College
    Inventors: Kathryn C. Stallcup, Matthew F. Mescher, Steven J. Burakoff